Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India underlines 'robust, balanced' IP regime at WIPO

This article was originally published in Scrip

Executive Summary

A senior Indian government minister has underlined to a meeting of the World Intellectual Property Organization that recent pharma-related patent decisions are not the whims of rogue officials or judges but are fully in line with India’s industry and development policies. The clear message to the world’s drug companies is that India will use whatever ‘flexibility’ exists in international intellectual property agreements to help reach its aspirations.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts